Atlas Trials

Weekly Topotecan in the Second-Line Treatment of Small Cell Lung Cancer

Clinical trial NCT00193388 · COMPLETED

Trial details

NCT number
NCT00193388
Sponsor
SCRI Development Innovations, LLC
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Lung Cancer
Start date
2002-09-01
Primary completion
2004-12-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.